Veroniquè Frattini
Pfizer (United States)(US)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Cancer, Hypoxia, and Metabolism, Neuroblastoma Research and Treatments, Ubiquitin and proteasome pathways, interferon and immune responses
Most-Cited Works
- → Clonal evolution of glioblastoma under therapy(2016)783 cited
- → The integrated landscape of driver genomic alterations in glioblastoma(2013)554 cited
- → Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma(2015)281 cited
- → Single-cell transcriptome analysis of lineage diversity in high-grade glioma(2018)259 cited
- → The molecular landscape of glioma in patients with Neurofibromatosis 1(2018)207 cited
- → A metabolic function of FGFR3-TACC3 gene fusions in cancer(2018)195 cited
- → An ID2-dependent mechanism for VHL inactivation in cancer(2016)126 cited
- → NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma(2012)93 cited
- → Pegasus: a comprehensive annotation and prediction tool for detection of driver gene fusions in cancer(2014)73 cited
- → A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment(2011)48 cited